Internal Medicine, Endocrinology, Diabetes, & Metabolism · Tupelo, MS
NPI
1760499867
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
670 Crossover Rd
Tupelo, MS, 38801
Phone (662) 844-8414
Groups this clinician bills Medicare through
Medicare paid, 2024
$460K
28,736 services
Medicare patients, 2024
1,641
Average age 73
Drug cost, 2024
$909K
5,704 prescriptions
Company payments, 2025
$2,538
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark D Shepherd was code 36415 (venipuncture blood collection), 2,280 times for 1,394 patients. In total Mark D Shepherd billed 28,736 services in 46 codes, and Medicare paid $460K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 2,280 | 1,394 | $8.52 | $19K |
| 84443 Clinical Chemistry | Office | 1,803 | 1,172 | $16.38 | $30K |
| 80053 Clinical Chemistry | Office | 1,638 | 1,072 | $10.31 | $17K |
| 99214 Office E&M - Established | Office | 1,609 | 1,180 | $78.61 | $126K |
| 80061 Clinical Chemistry | Office | 1,436 | 915 | $12.92 | $19K |
| 85025 Blood Count | Office | 1,390 | 930 | $7.59 | $11K |
| 83036 Blood Count | Office | 1,262 | 754 | $9.36 | $12K |
| 82043 Clinical Chemistry | Office | 1,210 | 751 | $5.57 | $6,742 |
| 84439 Clinical Chemistry | Office | 775 | 602 | $8.70 | $6,744 |
| 82306 Clinical Chemistry | Office | 568 | 522 | $28.63 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 509 | 384 | $11.65 | $5,928 |
| 99215 Office E&M - Established | Office | 508 | 380 | $116.75 | $59K |
| 83970 Clinical Chemistry | Office | 423 | 370 | $40.02 | $17K |
| 84100 Clinical Chemistry | Office | 344 | 314 | $4.61 | $1,585 |
| A9517 Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie | Office | 326 | 15 | $51.27 | $17K |
By year: 2022 $409K for 28,478 services; 2023 $440K for 25,860 services; 2024 $460K for 28,736 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,280 | 1,394 | $8.52 | $19K |
| 84443 Clinical Chemistry | 1,803 | 1,172 | $16.38 | $30K |
| 80053 Clinical Chemistry | 1,638 | 1,072 | $10.31 | $17K |
| 80061 Clinical Chemistry | 1,436 | 915 | $12.92 | $19K |
| 85025 Blood Count | 1,390 | 930 | $7.59 | $11K |
| 83036 Blood Count | 1,262 | 754 | $9.36 | $12K |
| 82043 Clinical Chemistry | 1,210 | 751 | $5.57 | $6,742 |
| 84439 Clinical Chemistry | 775 | 602 | $8.70 | $6,744 |
| 82306 Clinical Chemistry | 568 | 522 | $28.63 | $16K |
| 83970 Clinical Chemistry | 423 | 370 | $40.02 | $17K |
Medicare prescription drug claims, 2024
In 2024, the drug Mark D Shepherd prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,418 prescriptions and refills. In total Mark D Shepherd wrote 5,704 Medicare prescriptions that cost $909K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,418 | 3,662 | 390 | $12K |
| Alendronate Sodium Generic | 245 | 592 | 81 | $1,477 |
| Synthroid Levothyroxine Sodium | 212 | 443 | 49 | $14K |
| Metformin Hcl Er Metformin Hcl | 210 | 471 | 63 | $2,573 |
| Rosuvastatin Calcium Generic | 199 | 535 | 73 | $1,743 |
| Atorvastatin Calcium Generic | 180 | 482 | 57 | $1,476 |
| Ezetimibe Generic | 154 | 399 | 55 | $3,836 |
| Jardiance Empagliflozin | 128 | 190 | 39 | $111K |
| Allopurinol Generic | 107 | 228 | 28 | $938 |
| Glimepiride Generic | 105 | 229 | 39 | $633 |
| Testosterone Generic | 103 | 149 | 26 | $13K |
| Hydrocortisone Generic | 96 | 159 | 24 | $6,588 |
| Lisinopril Generic | 95 | 246 | 29 | $643 |
| Testosterone Cypionate Generic | 84 | 175 | 32 | $3,401 |
| Metformin Hcl Generic | 82 | 209 | 34 | $804 |
Brand drugs: 1,631 claims; generic drugs: 3,972 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark D Shepherd $2,538 ($2,538 in general payments such as food, travel and fees) from 30 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $274.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.